Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.64 +0.69 (2.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.95 | 52 Week High | $37.39 | |||
| Open | $30.51 | 52 Week Low | $28.25 | |||
| Day High | $30.67 | P/E | 18.57 | |||
| Day Low | $30.14 | EPS | $1.65 | |||
| Volume | 17,170,159 | |||||
